UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Evaluate the pros and cons of SP 500 ETFs versus index funds for IRAs, focusing on cost, diversification, and tax considerations.
24,931 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
In 1999, Mark Cuban reportedly earned more from hedging Yahoo shares with a protective collar than from selling Broad...
Strategy Inc. disclosed a fresh BTC purchase, increasing its digital asset reserve to 818,334 coins worth about $54 b...
Salesforce and Palantir posted strong quarters, but the market rewards or punishes them based on cash-return potentia...
A Washington retiree fell for a polished gold-coin scam, losing six figures and facing an IRMAA Medicare premium surp...
Investors chasing AI growth need to connect revenue signals to real opportunity. This analysis compares Astera Labs a...
A volatile week looms for crypto as macro headlines, geopolitics, and policy signals converge. Here are the five thin...
Rivian unveils the R2 with a sub-$45k price target and near-term shipments, while Lucid battles cash burn and no 2026...
A JPMorgan analyst forecasts looming oil shortages within weeks, drawing a sharp response from investors and fund man...
Memory-chip demand has surged with AI and cloud growth, but timing still matters. This guide breaks down how to evalu...
When a Netflix doc drops and sparks Emmy chatter, money, strategy, and fame collide. This guide explains what cent’s ...
Oracle beat on earnings and grew its contract backlog to a record level, yet investors pounced on higher AI costs, se...